Document is current
Any future updates will be listed below
-
Authors
Oikonomou, Evangelos K.
Khera, Rohan
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute, United States (F32HL170592, K23HL153775)
Doris Duke Charitable Foundation,United States (2022060)
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 7 September 2023
First Online: 25 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: E.K.O and R.K. are co-inventors of the U.S. Patent Applications 63/508,315 and 63/177,117 and co-founders of Evidence2Health, a health analytics company to improve evidence-based cardiovascular care. E.K.O. reports a consultancy and stock option agreement with Caristo Diagnostics Ltd (Oxford, U.K.), unrelated to the current work. R.K. received support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (under award K23HL153775) and the Doris Duke Charitable Foundation (under award 2022060). R.K. further receives research support, through Yale, from Bristol-Myers Squibb and Novo Nordisk, unrelated to current work. He is a coinventor of U.S. Pending Patent Applications 63/428,569 and 63/346,610, unrelated to the current work. He is an Associate Editor at JAMA.
